Octave Acquires Cerebre for Industrial AI Plant Models
Octave acquires Cerebre, the company said in a press release. Cerebre builds connected plant models from engineering schematics, plant data and operational knowledge.
Octave plans to combine these models with its engineering system of record for industrial facilities. AI applications can use the combined information to analyze a current representation of a plant, while engineering and operations teams retain final control over decisions.
Cerebre's capabilities will become available through the Octave platform and its engineering and operations products. Founded in 2019, Cerebre is deployed across more than 200 plants and expects $8 million in 2026 revenue, mostly from annual recurring revenue.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Nov 11 StitchStudio raises $8M for insurance AI products Nov 11 Stage 2 Capital Closes $100 Million for B2B AI Investments Nov 11 Enza Capital secures $21 million for African AI fund Nov 11 Goldman Sachs Forecasts Anthropic Revenue of $685 Billion by 2030 Nov 11 Anthropic Founders Could Each Sell About $250 Million in IPO StockAI Funding Brief
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Teradyne Robotics and Sereact Partner on Industrial Robot AI
Electric Plant raises $11.2 million for plant signal AI
Marble Cognition raises $3.75 million for AI process automation
Perplexity and Valarian Bring AI Tools Into Customer Infrastructure
OpenAI acquires Orchestra Bio to bring AI agents into drug development
Daily AI Brief: the AI news that matters, in your inbox.